2 results
Approved WMOCompleted
To compare the pharmacokinetic and pharmacodynamic profile of the rapid-acting insulin analogue aspart (NovorapidĀ®) injected with jet-injection to that of the same insulin injected with a conventional pen.
Approved WMORecruiting
Primary ObjectiveTo assess the efficacy of Kamada-AAT for Inhalation administered at a dose of 80 mg daily versus (vs) placebo, with efficacy measured by FEV1 post bronchodilator change from baseline at 104 weeks.Secondary ObjectiveTo assess theā¦